ATE328893T1 - Antibakterielle protonierte oligonukleotide - Google Patents

Antibakterielle protonierte oligonukleotide

Info

Publication number
ATE328893T1
ATE328893T1 AT99966301T AT99966301T ATE328893T1 AT E328893 T1 ATE328893 T1 AT E328893T1 AT 99966301 T AT99966301 T AT 99966301T AT 99966301 T AT99966301 T AT 99966301T AT E328893 T1 ATE328893 T1 AT E328893T1
Authority
AT
Austria
Prior art keywords
protonated
oligonucleotides
antibacterial
nucleic acids
resistant
Prior art date
Application number
AT99966301T
Other languages
English (en)
Inventor
Roderic M K Dale
Amy Arrow
Steven L Gatton
Terry Thompson
Original Assignee
Oligos Etc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oligos Etc Inc filed Critical Oligos Etc Inc
Application granted granted Critical
Publication of ATE328893T1 publication Critical patent/ATE328893T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99966301T 1998-12-30 1999-12-15 Antibakterielle protonierte oligonukleotide ATE328893T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/222,009 US6211349B1 (en) 1998-12-30 1998-12-30 Protonated/acidified nucleic acids and methods of use

Publications (1)

Publication Number Publication Date
ATE328893T1 true ATE328893T1 (de) 2006-06-15

Family

ID=22830357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966301T ATE328893T1 (de) 1998-12-30 1999-12-15 Antibakterielle protonierte oligonukleotide

Country Status (8)

Country Link
US (1) US6211349B1 (de)
EP (1) EP1140965B1 (de)
JP (1) JP2002534433A (de)
AT (1) ATE328893T1 (de)
AU (1) AU2187300A (de)
CA (1) CA2358570C (de)
DE (1) DE69931809T2 (de)
WO (1) WO2000040591A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US6627215B1 (en) * 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
US6211162B1 (en) * 1998-12-30 2001-04-03 Oligos Etc. Inc. Pulmonary delivery of protonated/acidified nucleic acids
US20050136458A1 (en) * 1998-12-31 2005-06-23 Oligos, Etc, Inc. Method for nucleic acid preparation
WO2003003975A2 (en) * 2001-06-04 2003-01-16 The General Hospital Corporation Detection and therapy of vulnerable plaque with photodynamic compounds
JP3602071B2 (ja) * 2001-06-05 2004-12-15 株式会社日立製作所 核酸の精製分離方法
US20030207834A1 (en) 2001-07-10 2003-11-06 Dale Roderic M.K. Oligonucleotide-containing pharmacological compositions and their use
US20040043950A1 (en) * 2002-01-03 2004-03-04 Board Of Regents, The University Of Texas System WT1 antisense oligos for the inhibition of breast cancer
NZ545360A (en) * 2003-08-28 2009-06-26 Novartis Ag Interfering RNA duplex having blunt-ends and 3'-modifications
WO2006122409A1 (en) * 2005-05-16 2006-11-23 Replicor Inc. Antimicrobial molecules and their uses
WO2007022642A2 (en) * 2005-08-25 2007-03-01 Replicor Inc. Anti-inflammatory molecules and their uses
GB0608838D0 (en) 2006-05-04 2006-06-14 Novartis Ag Organic compounds
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US20180258128A1 (en) 2017-03-10 2018-09-13 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US12030908B2 (en) 2017-03-10 2024-07-09 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11377468B2 (en) 2017-03-10 2022-07-05 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
AU2018282905B2 (en) 2017-06-12 2022-06-02 Lakewood Amedex, Inc Bisphosphocin gel formulations and uses thereof
CA3116157A1 (en) 2018-10-17 2020-04-23 Lakewood Amedex, Inc. Methods and compositions for treating oral mucositis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5115637A (en) * 1974-07-26 1976-02-07 Yukio Kobayashi Ch3 cooh to pentakurorufuenoorunokongonyoru satsukinseibutsushitsu
CA1231053A (en) * 1984-01-09 1988-01-05 Capetrol International, Inc. Germicides having ph values of less than about l
US5294533A (en) 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
ZA902710B (en) * 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
IL108206A0 (en) * 1993-01-06 1994-04-12 Univ Johns Hopkins Oligomers having improved stability at acid ph
GB9505438D0 (en) 1995-03-17 1995-05-03 Sod Conseils Rech Applic Antisense oligonucleotides
US5747256A (en) * 1995-12-19 1998-05-05 Beckman Instruments, Inc. Homogeneous DNA probe titration assay
AU3811897A (en) * 1996-07-24 1998-02-10 Oglios Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents

Also Published As

Publication number Publication date
CA2358570A1 (en) 2000-07-13
JP2002534433A (ja) 2002-10-15
CA2358570C (en) 2013-02-26
EP1140965B1 (de) 2006-06-07
EP1140965A1 (de) 2001-10-10
AU2187300A (en) 2000-07-24
US6211349B1 (en) 2001-04-03
DE69931809T2 (de) 2007-01-04
DE69931809D1 (de) 2006-07-20
WO2000040591A1 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
ATE328893T1 (de) Antibakterielle protonierte oligonukleotide
ATE247972T1 (de) Pulmonare abgabe von protonierter/angesäuerter nukleinsäure
JP2002510602A5 (de)
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
PT738107E (pt) Inibidores da sintese de acidos gordos como agentes antimicrobianos
DE60030124D1 (de) Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben
DE69516160D1 (de) Dihalopropenverbindungen, diese enthaltende insektizide/acarizide mittel und zwischenprodukte zur herstellung davon
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
CA2168963A1 (en) Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases
WO2001045679A3 (de) Verwendung von chemotherapeutika zur topischen behandlung
NO20002434L (no) Oksazolidinonderivater og farmasøytiske preparater
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
WO2003047341A3 (en) Anti-microbial systems and methods
AP2001002051A0 (en) Phosphorous organic compounds and their use.
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
CA3242451A1 (en) An injectable pharmaceutical composition for the treatment of respiratory diseases in animals
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
AU740327C (en) Carbapenem compounds, use thereof and intermediate compound therefor
EP0856519A3 (de) Antibakterielles Insektenprotein
DE602004017586D1 (de) Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus
FR2809586B1 (fr) Engin automoteur notamment pour operations de traitement et d'entretien de cultures

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties